HIV testing and treatment for newborns
Part of Genetic & congenital clinical trials.
This study looks at ways to test and treat newborns for HIV early to improve their long-term health. It is for mothers with HIV whose babies are less than 3 days old and who are willing to have their babies tested and followed at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a mother or legal guardian who is at least 18 years old.
- You have HIV and are willing to have your baby tested for HIV.
- Your baby is less than 3 days old (born within the last 72 hours).
- You are willing to be contacted at home if needed for follow-up.
- Your baby is healthy and does not need emergency care or have serious health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a combination of two lab-made antibodies (PGT121.414.LS and VRC07-523LS) to newborns exposed to HIV during pregnancy is safe and how the body processes them. It may help protect infants from getting HIV after birth.
This study gives very early, intensive HIV medicine to infants diagnosed with HIV and follows them closely to see if HIV can go into remission (stop being detectable without ongoing treatment). It may help families understand whether treating right after birth can change a child’s long-term HIV outlook.
This trial tests an experimental vaccine for babies who were exposed to HIV while in the womb but are not infected. Mothers must be living with HIV, on treatment, and deliver by C-section at the study hospital in Soweto.
This study tests a long-acting injectable HIV prevention medicine called cabotegravir in newborn babies who were exposed to HIV. The goal is to see if it can help protect them from getting HIV.
This study follows pregnant women with viral infections (like HIV or hepatitis) and their babies to see how the infection and treatments affect both. It aims to improve care for mothers and children.
This study tests whether giving a special antibody treatment to babies living with HIV, shortly after birth, can help their immune system fight the virus better. It aims to improve their long-term health.
Hear when a new Infant Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.